Chief Executive Officer Adam Steensberg has actually formerly explained the firm’s long-acting amylin analog, petrelintide, as the “crown gem” of Zealand Pharma’s pipe.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/zealand-pharma-enrolls-first-patient-in-new-study-with-crown-jewel/